000026282 000__ 01493cam\a2200481\i\4500
000026282 001__ 26282
000026282 003__ SzGeWIPO
000026282 005__ 20240708162359.0
000026282 008__ 080111s2010    nju|||||r|||| 00| 0 eng d
000026282 035__ $$a(wipo)0
000026282 035__ $$a(OCoLC)1159938662
000026282 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000026282 041__ $$aeng
000026282 043__ $$aa-ii---
000026282 050_4 $$aK1401.A15$$bJ68
000026282 08204 $$a346.048$$220
000026282 084__ $$aCH 51
000026282 1001_ $$aMey, B. P.
000026282 24510 $$aUnfettered Consumer Access to Affordable Therapies in the Post-TRIPS Era :$$bA Dead-End Journey for Patients? Kenya and India Case Studies.
000026282 264_1 $$aHoboken, New Jersey :$$bJohn Wiley & Sons, Inc.,$$c2010.
000026282 300__ $$a1 volume ([71] pages) ;$$c[28] cm.
000026282 336__ $$atext$$btxt$$2rdacontent
000026282 337__ $$aunmediated$$bn$$2rdamedia
000026282 338__ $$avolume$$bnc$$2rdacarrier
000026282 4901_ $$aThe Journal Of World Intellectual Property,$$x1422-2213 ;$$vCH 51 Jan 2010 Vol. 13 No. 3 pages 403-473
000026282 650_0 $$aIntellectual property (International law)
000026282 650_0 $$aCopyright, International.
000026282 650_0 $$aPatents (International law)
000026282 650_0 $$aDispute resolution (Law)$$zCanada.
000026282 650_0 $$aIntellectual property$$zIndia.
000026282 650_4 $$aCase studies$$zKenya$$zIndia
000026282 650_4 $$aTRIPS
000026282 650_4 $$aDrugs$$xPharmaceutical industry
000026282 650_6 $$aPropriété intellectuelle (Droit international)
000026282 651_0 $$aIndia$$xCommerce$$xLaw and legislation.
000026282 8564_ $$uhttp://dx.doi.org/10.1111/j.1747-1796.2009.00392.x$$y[Access for WIPO staff only]
000026282 8564_ $$uDOI: 10.1111/j.1747-1796.2008.00344.x
000026282 903__ $$aThe Journal of World Intellectual Property.
000026282 904__ $$aJournal article
000026282 942__ $$cART$$jCH 51 Jan 2010 Vol. 13 No. 3$$2ddc
000026282 952__ $$w2011-01-19$$p2011-0055$$u40528$$bMAIN$$10$$kCH 51$$v2011-01-19$$70$$cMain Library$$yART
000026282 980__ $$aBIB
000026282 999__ $$c28673$$d28673